| Line Item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE LOSS | ||||||
| Revenue | ||||||
| Cost of revenue | ||||||
| Gross profit | ||||||
| Operating expenses: | ||||||
| Research and development | ||||||
| Selling and marketing | ||||||
| General and administrative | ||||||
| Reorganization (Note 9) | — | |||||
| Total operating expenses | ||||||
| Operating loss | ||||||
| Change in fair value of warrants | ||||||
| Finance income | ||||||
| Finance expenses | ||||||
| Finance income, net | ||||||
| Loss before income taxes | ||||||
| Income taxes, net | ||||||
| Loss | ||||||
| Amounts that will be or that have been reclassified to profit or loss when specific conditions are met: | ||||||
| Adjustments arising from translating financial statements of foreign operations | ||||||
| Total comprehensive loss | ||||||
| Basic loss per Ordinary share (Note 10) | ||||||
| Diluted loss per Ordinary share (Note 10) |